Samil Pharmaceutical Co.,Ltd

₩7,340As of Sun 8 Nov 2026, 12:00 UTC
KRX:000520Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 8.69%
Div yield —
ROE (27.37%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM —
TSR TTM (22.74%)
Mkt cap ₩156.9B
ROIC (10.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,887
21.07%
(84.14%)
Hold 12|0|12|6|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
180.41
199.01
214.93
219.88
15.76%
26.01%
31.37%
36.05%
Revenue₩B
10.82
10.81
10.51
10.23
7.59%
6.99%
1.46%
(3.41%)
Peers (US$115.6M)
Cap (US$)
PE
121.4M
—
119.4M
6.226x
110.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.604
0.290
0.239
EBIT/Intx
0.621
1.145
1.068
Own earn%
374.69
9.81
1.23
Sh yield%
30.29
26.94
31.16
Owners
Insiders/Inst%
10.41
49.05
Short interest%
3.55
SBC / revenue%
3.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
10–14
$1 testx
—
Incr. ROIC%
3